(11.BETA.,16.ALPHA.,17.ALPHA.)-9-CHLORO-17-(2,2-DIOXIDO-5H-1,2-OXATHIOL-4-YL)-17-((2-FURANYLCARBONYL)OXY)-11-HYDROXY-16-METHYLANDROSTA-1,4-DIEN-3-ONE
UNII 8MZU56S9QP
Substance Identification & Data
This profile provides standardized clinical and technical data for (11.beta.,16.alpha.,17.alpha.)-9-chloro-17-(2,2-dioxido-5h-1,2-oxathiol-4-yl)-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methylandrosta-1,4-dien-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8MZU56S9QP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 223776-49-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H31ClO8S CICBZJUKOHKGNN-YRGVOICOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (11.beta.,16.alpha.,17.alpha.)-9-chloro-17-(2,2-dioxido-5h-1,2-oxathiol-4-yl)-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methylandrosta-1,4-dien-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.